Health

Zepp Health Corporation Files 2022 Annual Report on Form 20-F

BEIJING, April 24, 2023 /PRNewswire/ -- Zepp Health Corporation ("Zepp Health" or the "Company") (NYSE: ZEPP), a cloud-based healthcare services provider with world-leading smart wearable technology, today announced that it has filed its annual report on Form 20-F for the full year endedDecember ...

2023-04-25 05:20 2691

EDAN Presented a Regional Development Blueprint for the Delegation from the Colombian Consulate

SHENZHEN, China, April 24, 2023 /PRNewswire/ -- The Consul General of Colombia inGuangzhou, Hernan Vargas Martin, led a delegation to visit the headquarter of Edan Instruments, Inc. (300206.SZ) in Shenzhen , and exchanged development strategies and actions of Lati...

2023-04-24 23:12 2785

A new super factory with 29 GMP grade production lines for gene and cell therapy was launched in Shanghai by OBiO technology

SHANGHAI, April 24, 2023 /PRNewswire/ -- On April 21, 2023, OBiO Technology ( Shanghai) Corp., Ltd. ("OBiO" or "the Company"), a leading gene and cell therapy CDMO inChina, announced the launching of a new GMP manufacturing base, named OBiO Intelli-M. The new base was located in theChina (Shang...

2023-04-24 22:36 2985

CJ FNT Launches Functional Nutrition Brand, "ActiveNrich™"

*  A new Specialty brand focusing on nutritional solutions for food and supplement categories catering to the customer needs *  ActiveNrich™ is making its global debut with natural antioxidant solution in Q2 SEOUL, South Korea, April 24, 2023 /PRNewswire/ -- CJ Food & Nutrition Tech (CJ FNT) ...

2023-04-24 21:00 1875

AITRICS to Participate in HIMSS USA 2023

* Introducing an AI Solution for predicting patient deterioration, 'VitalCare' * Second HIMSS USA Participation...Finding potential customers and establishing a foothold in the US market SEOUL, South Korea, April 24, 2023 /PRNewswire/ -- AITRICS (CEO Kwang joon Kim, Jin-gyu Yoo), a company spe...

2023-04-24 21:00 1769

I-Mab Announces First Patient Dosed in Phase 3 Registrational Study of CD47 Antibody Lemzoparlimab in MDS in China

GAITHERSBURG, Md. and SHANGHAI, April 24, 2023 /PRNewswire/ -- I-Mab (the "Company") (Nasdaq: IMAB), a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, today announced that the first patient in a Phase 3 registrational tri...

2023-04-24 21:00 1918

DetectedX Launches MyImageDx Online Learning Platform for Radiology Educators at Association of University Radiologists and Society of Breast Imaging Meetings

Fully Customizable Interactive Learning Platform Enables Educators to Deliver Image-Based Learning using DetectedX's Award-Winning Online Training Technology and Tools SYDNEY, April 24, 2023 /PRNewswire/ -- DetectedX, the leaders in intelligent interactive educational technology, announced today...

2023-04-24 20:00 1628

BIORCHESTRA Announces Significant Progress in Studies of BMD-001 Drug Program

* Encouraging non-human primate (NHP) findings support the progression of IV-formulatedBMD-001 ahead of formal clinical studies for Alzheimer's disease, Amyotrophic Lateral Sclerosis, and Parkinson's disease * Further validation of Brain Targeting RNAi Nanomedicine (BTRiNTM), including target...

2023-04-24 20:00 1393

Four innovative drugs launched in three years, HKEX -Listed Simcere Pharmaceutical Group is on the Fast Track Toward Building an Innovation-Driven Global Pharmaceutical Company

-The revenue from innovative drugs accounted for more than 65% of total revenue  -Simcere's total revenue and the revenue from innovative drugs hit record highs. NANJING, China, April 24, 2023 /PRNewswire/ -- On Apr. 18, Simcere Pharmaceutical (2096.HK) disclosed the latest progress on the compa...

2023-04-24 18:09 2392

WuXi AppTec Continued Solid Growth in First-Quarter of 2023 On Top of an Exceptionally Strong Year of 2022

Revenue Up 5.8% Year-Over-Year to RMB8,964 Million Net Profit Attributable to Owners of the Company Up 32.0% Year-Over-Year to RMB2,168 Million Diluted Earnings per Share (EPS) Up 35.8% Year-Over-Year to RMB0.72 Adjusted Non-IFRS Net Profit Attributable to Owners of the Company Up 14.1% Year-Over-...

2023-04-24 18:03 2365

Tibetan medicine advanced over past decade

BEIJING, April 24, 2023 /PRNewswire/ -- A news report from chinadaily.com.cn: Adhering to an equal emphasis on traditional Chinese and Western medicine, the government of the Tibet autonomous region has increased financial investment, formulated supportive policies and promoted the development of...

2023-04-24 17:04 1387

Samsung Biologics Reports First Quarter 2023 Financial Results

* Recorded Q1'23 consolidated revenue of KRW 720.9 billion. * Recorded Q1'23 consolidated operating profit of KRW 191.7 billion. * Expected to maintain a strong growth trajectory with the full utilization of existing and newly expanded capacities. INCHEON, South Korea, April 24, 2023 /PRNews...

2023-04-24 14:51 2260

Zylox-Tonbridge enters into strategic cooperation with Hicicare for innovative Chinese vascular guidewires solutions

HANGZHOU, China, April 23, 2023 /PRNewswire/ -- Zylox-Tonbridge Medical Technology Co., Ltd. (2190. HK, the "Company") announced the signing of a strategic agreement with Guangdong Hicicare Science Co., Ltd. ("Hicicare"). With the collaboration, Zylox-Tonbridge and Hicicare plan to introduce and ...

2023-04-24 10:36 1924

Bridge Biotherapeutics Receives FDA Authorization to Proceed with the First-in-Human Study of BBT-207, a 4th generation EGFR TKI

* The company has been notified by the FDA that the Phase 1/2 clinical trial may proceed * The latest preclinical data explored the antitumor efficacy and the intracranial activity of BBT-207 SEONGNAM, South Korea and CAMBRIDGE, Mass., April 23, 2023 /PRNewswire/ -- Bridge Biotherapeutics (KQ...

2023-04-24 10:00 1642

Patsnap Unveils Synapse Visitor, the Latest AI-Powered Pharmaceutical Intelligence Platform

LONDON, April 23, 2023 /PRNewswire/ -- On April 20, Patsnap, the world's leading SaaS provider for intelligence, announced the launch of its latest version of the intelligence platform, Synapse, available to visitors. This version includes advanced search functions for drugs and pharmaceutical o...

2023-04-24 08:00 2615

ITRI Took Home Three Edison Awards(TM) in 2023

HSINCHU, April 21, 2023 /PRNewswire/ -- The highly-anticipated 2023 Edison Awards™ winners were revealed in Fort Myers, Florida , and the Industrial Technology Research Institute (ITRI ) is proud to be among them. The ITRI team attended the awa...

2023-04-21 19:27 3137

ImmVira Appoints Dr. Oliver Kong as Chief Medical Officer

SHENZHEN, China, April 20, 2023 /PRNewswire/ -- On April 17, 2023, ImmVira announced the appointment of Dr.Oliver Kong as Chief Medical Officer (CMO). Dr. Kong will be fully in charge of global clinical development and international collaboration of company pipelines, and participate in overall c...

2023-04-21 09:06 2111

More than ten thousand dollars send away as bonuses in the Boston Online Marathon

HOUSTON, April 20, 2023 /PRNewswire/ -- The PitPat Boston Online Marathon is still underway. According to PitPat, more than 1,000 people have signed up and nearly 200 have finished. PitPat Online Marathon The Boston Online Mar...

2023-04-20 23:00 2008

CARsgen's CAR T-cell Candidate CT041 Achieves IND Clearance from the NMPA for the Postoperative Adjuvant Therapy of Pancreatic Cancer

SHANGHAI, April 20, 2023 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors, announced that CT041, an autologous CAR T-cell product candidate against the p...

2023-04-20 20:50 2388

Samyang Holdings Enters Partnership with LG Chem for the Development of Innovative Cancer Therapeutics

* Implementation of Samyang Holdings' drug delivery technology for the development of mRNA-based cancer therapeutics SEOUL, South Korea, April 20, 2023 /PRNewswire/ -- Samyang Holdings and LG Chem have announced their recent execution of strategic partnership agreement onThursday, April 20th, f...

2023-04-20 20:30 1768
1 ... 101102103104105106107 ... 280